AI-generated summary
The authors randomly treated split café-au-lait macules in 41 patients with a 755 nm picosecond laser, a 755 nm nanosecond laser, or a 532 nm nanosecond laser. Visual assessments three months later showed no statistically significant difference among the three lasers, and the picosecond laser caused fewer adverse effects. Adverse effects were generally resolved within 12 months, and the authors recommend patch testing before treatment.
- Participants
- 41
- Who or what was studied
- Patients with café-au-lait macules (CALMs) who received several treatments at 3-month intervals; the abstract reports 19 patients in the follow-up outcomes.
- Wavelengths
- 755, 532 nm
- Limits stated in the abstract
- The abstract reports only 19 of 41 patients in outcome analyses and gives no information on sample size, control group or follow-up beyond 3 months.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 755 nm, 532 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.